Perspective of Vaccine Manufacturers on Financing Pediatric and Adolescent Vaccines in the United States
Open Access
- 1 December 2009
- journal article
- Published by American Academy of Pediatrics (AAP)
- Vol. 124 (Supplement) , S540-S547
- https://doi.org/10.1542/peds.2009-1542n
Abstract
OBJECTIVE: The goal was to understand vaccine manufacturers' perspectives on vaccine financing as a barrier to immunization.Keywords
This publication has 14 references indexed in Scilit:
- Financing the Delivery of Vaccines to Children and Adolescents: Challenges to the Current SystemPediatrics, 2009
- Net Financial Gain or Loss From Vaccination in Pediatric Medical PracticesPediatrics, 2009
- Primary Care Physician Perspectives on Reimbursement for Childhood ImmunizationsPublished by American Academy of Pediatrics (AAP) ,2008
- Variation in Provider Vaccine Purchase Prices and Payer ReimbursementPublished by American Academy of Pediatrics (AAP) ,2008
- Vaccine Shortages: Why They Occur and What Needs to Be Done to Strengthen Vaccine SupplyPublished by American Academy of Pediatrics (AAP) ,2006
- Factors Affecting U.S. Manufacturers’ Decisions To Produce VaccinesHealth Affairs, 2005
- Why Certain Vaccines Have Been Delayed Or Not Developed At AllHealth Affairs, 2005
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Lessons Learned From a Review of the Development of Selected VaccinesPediatrics, 1999
- The Comprehensive Childhood Immunization Act of 1993: Toward a More Rational ApproachNew England Journal of Medicine, 1993